Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cochlear.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Powerplays: Health stocks on a wave of jitters as inflation storm gathers
Health & Biotech
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Experts
ScoPo’s Powerplays: ‘We’ve gone from a boiled lolly to a prize-winning chocolate in the space of a week’
Experts
ScoPo’s Powerplays: These ASX health stocks are under the radar as market wallows
Health & Biotech
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks
News
ASX Large Caps: Local shares tumble over 1pc as Ukraine tensions continue to dictate market
Health & Biotech
ASX Health Stocks: Cochlear’s profit down 28pc in first half, as Estia’s aged care struggles with Omicron outbreak
Experts
ScoPo’s Powerplays: Who’s pulling for a health sector recovery?
News
The Ethical Investor: What the Big Oil rebound means for ESG; and Australian Ethical’s Mike Murray on new ESG ETF
News
Here are the top ASX large cap movers for Wednesday
ScoPo’s Powerplays: ‘Market volatility could lead to a rally by Christmas’
Director Trades
Directors’ Trades: Otto Buttula buys another $580k of Rhythm Biosciences shares
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ASX Health Stocks: Chimeric gets FDA clearance, Cochlear posts record sales
News
Market Highlights and 5 ASX Small Caps to watch on Friday
Health & Biotech
